| MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18 R Salcedo, A Worschech, M Cardone, Y Jones, Z Gyulai, RM Dai, E Wang, ... Journal of Experimental Medicine 207 (8), 1625-1636, 2010 | 486 | 2010 |
| Human genetic and immunological determinants of critical COVID-19 pneumonia CHGE Qian Zhang, Paul Bastard, JLC Aurélie Cobat Nature 603, 587-598, 2022 | 282 | 2022 |
| Tuberculosis and impaired IL-23–dependent IFN-γ immunity in humans homozygous for a common TYK2 missense variant S Boisson-Dupuis, N Ramirez-Alejo, Z Li, E Patin, G Rao, G Kerner, ... Science immunology 3 (30), eaau8714, 2018 | 195 | 2018 |
| The immunologic constant of rejection E Wang, A Worschech, FM Marincola Trends in immunology 29 (6), 256-262, 2008 | 179 | 2008 |
| Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma Q Xie, R Bradley, L Kang, J Koeman, ML Ascierto, A Worschech, ... Proceedings of the National Academy of Sciences 109 (2), 570-575, 2012 | 148 | 2012 |
| HER‐2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell‐mediated anti‐tumor immune responses M Kmieciak, KL Knutson, CI Dumur, MH Manjili European journal of immunology 37 (3), 675-685, 2007 | 131 | 2007 |
| Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy A Worschech, N Chen, YA Yu, Q Zhang, Z Pos, S Weibel, V Raab, ... BMC genomics 10, 1-22, 2009 | 110 | 2009 |
| Humans with inherited T cell CD28 deficiency are susceptible to skin papillomaviruses but are otherwise healthy V Béziat, F Rapaport, J Hu, M Titeux, MB Des Claustres, M Bourgey, ... Cell 184 (14), 3812-3828. e30, 2021 | 73 | 2021 |
| Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection S Weibel, V Raab, YA Yu, A Worschech, E Wang, FM Marincola, ... BMC cancer 11, 1-17, 2011 | 62 | 2011 |
| The immunologic aspects of poxvirus oncolytic therapy A Worschech, D Haddad, DF Stroncek, E Wang, FM Marincola, AA Szalay Cancer Immunology, Immunotherapy 58, 1355-1362, 2009 | 54 | 2009 |
| Signatures Associated with Rejection or Recurrence in HER-2/neu–Positive Mammary Tumors A Worschech, M Kmieciak, KL Knutson, HD Bear, AA Szalay, E Wang, ... Cancer research 68 (7), 2436-2446, 2008 | 54 | 2008 |
| Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model H Yang, W Chen, X Cao, A Worschech, L Du, W Fang, Y Xu, DF Stroncek, ... Journal of Translational Medicine 7, 1-13, 2009 | 48 | 2009 |
| Impaired IL-23–dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency M Ogishi, AA Arias, R Yang, JE Han, P Zhang, D Rinchai, J Halpern, ... Journal of Experimental Medicine 219 (10), e20220094, 2022 | 47 | 2022 |
| Distinct signatures of the immune responses in low risk versus high risk neuroblastoma M Gowda, K Godder, M Kmieciak, A Worschech, ML Ascierto, E Wang, ... Journal of Translational Medicine 9, 1-8, 2011 | 47 | 2011 |
| Comprehensive molecular characterization of human adipocytes reveals a transient brown phenotype A Guennoun, M Kazantzis, R Thomas, M Wabitsch, D Tews, ... Journal of translational medicine 13, 1-18, 2015 | 46 | 2015 |
| Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A/F and TGF-β J Li, M Ritelli, CS Ma, G Rao, T Habib, E Corvilain, S Bougarn, S Cypowyj, ... Science immunology 4 (41), eaax7965, 2019 | 43 | 2019 |
| Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: potential relevance for adenoviral gene therapy V Monsurrò, S Beghelli, R Wang, S Barbi, S Coin, G Di Pasquale, ... Journal of Translational Medicine 8, 1-11, 2010 | 42 | 2010 |
| The immune-related role of BRAF in melanoma S Tomei, D Bedognetti, V De Giorgi, M Sommariva, S Civini, J Reinboth, ... Molecular oncology 9 (1), 93-104, 2015 | 36 | 2015 |
| Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68 ML Ascierto, A Worschech, Z Yu, S Adams, J Reinboth, NG Chen, Z Pos, ... BMC cancer 11, 1-14, 2011 | 31 | 2011 |
| CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancer M Kmieciak, A Worschech, H Nikizad, M Gowda, M Habibi, A Depcrynski, ... Breast cancer research and treatment 126, 385-394, 2011 | 28 | 2011 |
